Sponsor Pipeline

Shanghai Epiprobe Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06912672 Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma Urothelial Carcinoma Not Yet Recruiting
Disease Areas
Bladder Cancer (1)
Get alerts when Shanghai Epiprobe Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free